Global Immunohematology Market

Immunohematology Market Size, Share, Growth Analysis, By Product(Immunohematology analyzer, Immunohematology reagent), By End Use(Hospitals, Blood banks, Diagnostic laboratories ), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35G2186 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 34 | Figures: 74

Immunohematology Market Competitive Landscape

The global immunohematology market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Immunohematologys. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.

Immunohematology Market Top Player’s Company Profiles

  • Grifols 
  • QuidelOrtho 
  • Immucor 
  • Bio-Rad Laboratories 
  • Beckman Coulter 
  • Novartis 
  • Quotient Limited 
  • Diagast 
  • Becton, Dickinson and Company 
  • Thermo Fisher Scientific 
  • Abbott Laboratories 
  • BioMérieux 
  • Hologic, Inc. 
  • Werfen S.A. 
  • Merck KGaA 
  • DiaSorin S.p.A. 
  • F. Hoffmann-La Roche AG 
  • Immucor Gamma Biologics 
  • Tulip Diagnostics Pvt. Ltd. 
  • Versiti

Immunohematology Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Immunohematology Market size was valued at USD 1.83 billion in 2022 and is poised to grow from USD 1.92 billion in 2023 to USD 2.76 billion by 2031, growing at a CAGR of 4.63% during the forecast period (2024-2031).

The global immunohematology market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Immunohematologys. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. 'Grifols ', 'QuidelOrtho ', 'Immucor ', 'Bio-Rad Laboratories ', 'Beckman Coulter ', 'Novartis ', 'Quotient Limited ', 'Diagast ', 'Becton, Dickinson and Company ', 'Thermo Fisher Scientific ', 'Abbott Laboratories ', 'BioMérieux ', 'Hologic, Inc. ', 'Werfen S.A. ', 'Merck KGaA ', 'DiaSorin S.p.A. ', 'F. Hoffmann-La Roche AG ', 'Immucor Gamma Biologics ', 'Tulip Diagnostics Pvt. Ltd. ', 'Versiti'

One driver of the global immunohematology market is the increasing demand for blood transfusion services. With the rising prevalence of chronic diseases, surgical procedures, and trauma cases, there is a growing need for safe and compatible blood products for transfusion. Immunohematology plays a crucial role in ensuring the compatibility of blood products with the recipient's blood type, reducing the risk of adverse reactions and improving patient outcomes. This drives the adoption of immunohematology testing and related products in healthcare settings.

One key market trend in the global immunohematology market is the increasing adoption of automated and integrated systems for blood typing and cross-matching. With advancements in technology, there is a growing demand for efficient and accurate immunohematology testing methods. Automated systems offer benefits such as reduced human errors, improved workflow efficiency, and faster turnaround time for test results. These systems integrate various processes, including sample preparation, antibody identification, and data analysis, into a single platform, enhancing laboratory productivity. Furthermore, the integration of immunohematology systems with laboratory information management systems (LIMS) allows for seamless data management and improved traceability. The shift towards automation and integration in immunohematology is driven by the need for enhanced patient safety, increased efficiency, and improved laboratory performance.

One dominant region in the global immunohematology market is North America. This region has a well-established healthcare infrastructure and a high demand for blood products due to a large population and a significant number of medical procedures. The presence of key market players, technological advancements, and government initiatives promoting safe blood transfusion practices contribute to the dominance of North America in the Immunohematology market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Immunology Market
Buy Now GET FREE SAMPLE
Immunoassay Market
Buy Now GET FREE SAMPLE
Immunohistochemistry Market
Buy Now GET FREE SAMPLE
Immunodiagnostics Market
Buy Now GET FREE SAMPLE
Immunoglobulin Market
Buy Now GET FREE SAMPLE
Veterinary Immunodiagnostics Market
Buy Now GET FREE SAMPLE
Cancer Immunotherapy Market
Buy Now GET FREE SAMPLE
Allergy Immunotherapy Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Immunohematology Market

Report ID: SQMIG35G2186

$5,300
BUY NOW GET FREE SAMPLE